A B S T R A C T The lysis time of euglobulin clots made with whole blood (plasma and red cells) was very much shorter than that of clots made with plasma alone, indicating a fibrinolytic component in red cells. A plasminogen activator was found in the stroma-free hemolysate, and proteolytic activity was found in the stromal fraction. The plasminogen activator, purified by using diethylaminoethyl-cellulose (DEAE-cellulose) in a batch procedure followed by column chromatography, was called erythrokinase (EK). On preliminary characterization, EK appears to activate human and bovine plasminogen in a manner similar to urokinase (UK), as determined by fibrinolytic and caseinolytic assays. The two enzymes can be separated by DEAE chromatography and acrylamide-gel electrophoresis, however, and they hydrolyze acetyl-L-lysine methyl ester and benzoyl arginine methyl ester at different rates.
INTRODUCTION
The plasminogen activators streptokinase (SK), from the hemolytic streptococcus, and urokinase (UK), from human urine, have been used under controlled conditions to produce experimental thrombolysis in man (1, 2) . However, it has been shown that thrombolysis in vivo is influenced by the amounts of the various fibrinolytic components in plasma (3) , other body fluids (4), various tissues (5) , and by the components of the thrombus itself: fibrin stabilizing factor, fibrin, platelets (6) , white blood cells (7) , and erythrocytes (8) .
Although large numbers of erythrocytes are usually enmeshed in thrombi, there has been relatively limited HEMOLYZED RED CELLS ADDED, ml FIGURE 1 Effect of increasing amounts of red cells on plasma euglobulin lysis time. Varying amounts of washed, hemolyzed red cells from one subject were added to a constant amount of his plasma (0.7 ml), and the euglobulin precipitated from this mixture was reconstituted in saline phosphate buffer.
aniline black or cut with a Canalco lateral gel slicer into discs 1.0 mm thick. The discs were eluted for assay with 1 M NaCl and dialyzed against 0.01 M phosphate-buffered normal saline, pH 7.2. Measurement of fibrinolytic activity. The clot lysis time was used to measure the fibrinolytic activity of euglobulin fractions from whole blood or plasma (16) . The activity of column fractions was measured on heated and unheated bovine fibrin plates (17) to differentiate activator and plasmin. The activator activity of UK' and partially purified EK was determined by a standard clot fibrinolytic assay system on intermediate-or high-purity soluble plasminogen (with < 1% spontaneous plasmin activity) and a caseinolytic assay system (alpha casein) (16, 18) . Protein determinations were carried out on these materials by the biuret procedure (19) . Esterase activity of UK and EK was measured by hydrolysis of benzoyl arginine methyl ester (BAMe)' and acetyl-L-lysine methyl ester (ALMe)' (20) .
The effect of different fibrinolytic inhibitors on EK and UK was also determined (16, 21 7 .0. When 5% dextrose was used in a settling tank to aggregate and wash large volumes of red cells, the freeze-thawing step was omitted. These stroma-containing solutions will be called the original hemolysate.
RESULTS
The whole-blood euglobulin lysis time was previously found to be shorter than the plasma euglobulin lysis time at all levels of fibrinolytic activity (16) . For example, the average lysis time for 33 normal men and women was 66 ±6 min (SE) for whole-blood euglobulin and 162 ±24 min (SE) for plasma euglobulin. In view of this marked difference in activity, varying amounts of hemolyzed red cells were added to a constant volume of plasma. The euglobulin fraction was prepared for each dilution, and reconstituted to a final volume of 1.0 ml. Fig. 1 shows that lysis was enhanced by increasing amounts of hemolyzed red cells. In view of this observation, attempts were made to isolate the erythrocyte factor responsible for the enhanced fibrinolytic activity. The intact washed erythrocytes had little or no fibrinolytic activity when tested by the sensitive fibrin plate method. However, when the stroma was separated from the original hemolysate by centrifugation in a preparative ultracentrifuge' at 150,-000 g, fibrin plate assays indicated proteolytic activity with little activator in the stroma, 80 mm2 (SE ±9) on heated bovine fibrin plates and 84 mm' (SE ±9) on unheated plates. Activator with little proteolytic activity was found in the stroma-free hemolysate; the zone of lysis was 66 mm' (SE ±5) on unheated bovine fibrin plates and 9 mm' (SE ±5) on the heated plates.
Purification of EK. DEAE-cellulose was used in a batch procedure for preliminary separation of EK from hemoglobin in the original hemolysate, since Hennessey, Waltersdorph, Huennekens, and Gabrio (22) reported that hemoglobin was not adsorbed on DEAE-cellulose. A 5% suspension of DEAE in phosphate buffer was added to the original hemolysate in a 1: 150 ratio (v/v), the mixture was stirred at 4VC for 10 min, and the he- ' Spinco model L Ultracentrifuge, Spinco Division, Beckman Instruments, Inc., Fullerton, Calif. moglobin-containing supernatant was decanted. Additional hemoglobin and the plasmin-like proteolytic activity were removed by washing the DEAE-cellulose with phosphate buffer until the final wash was colorless. This washed DEAE-cellulose, with adsorbed activator, was placed on the top of a previously prepared DEAE column so that the added portion represented less than 10% of the total volume. EK was then eluted from the column with 0.5 M KC1, and 10 ml samples were collected. The optical density of each sample was determined at 280 mu (Fig. 2) . (When the original hemolysate was placed directly on the column, proteolytic activity was noted in the main protein area which was found to be clearly separated from activator activity.) Material from the activator peak area, dialyzed against distilled water, lyophilized, and reconstituted in phosphate buffer, was used in all subsequent studies.
The EK preparation contained 750 CTA U"/mg protein, representing at least 1000-fold purification over the original hemolysate. In contrast, the potency of highly purified urokinase preparations is approximately 'Activity of the EK unit is expressed in similar terms to that of the CTA unit of UK, as recently defined by the Committee on Thrombolytic Agents (CTA) of the National Heart Institute (18) . (24) . In this procedure, 0.1 ml of a l l B kaolin suspension in normal saline was incubated with blank; thus, no clot-promoting or thromboplastic activity was demonstrable under these conditions.
Differentiation from urokinase. Erythrokinase and urokinase were clearly differentiated by various techniques, including acrylamide-gel electrophoresis ( gel electrophoresis; the EK activity in two of them (11,000 and 3800 U/mg protein, respectively) represented 55% of the total protein in the preparation. The third band contained none. Erythrokinase and urokinase were also clearly differentiated through study of the hydrolysis of benzoyl arginine methyl ester. The rate of hydrolysis of BAMe by these enzymes was independent of substrate con-200 300 TIME, minutes 500 FIGURE 6 Effect of increasing temperature on denaturation of erythrocyte activator.
centration, indicating zero order kinetics, at or above 5 x 10-4 M BAMe (20) . Under these conditions, the reaction rate for EK was found to be approximately 2.8 times that for UK. Equivalent units of each enzyme were used over a range of 250-2500 CTA U at a BAMe concentration of 1 X 10' M (Table I) . Similarly, when data from hydrolysis of acetyl-L-lysine methyl ester were plotted by the Lineweaver and Burk method (25), differences were noted in the Michaelis constants (Ki)
and maximum velocities (V.), as shown in Fig. 8 .
When EK isolated by the above procedure was mixed with UK and chromatographed on DEAE-cellulose, peaks of the two enzymes were clearly separated (Fig.   9 ). Control runs with UK and EK, respectively, confirmed the individual identities of the peaks.
EK and UK must have a very similar mode of action, however, since both enzymes were inhibited by almost the same concentrations of all but one of the fibrinolytic inhibitors tested, the exception being 4-aminomethylbenzoic acid (Table II) .
, . . (26) . Since the partially purified erythrocyte activator contains no proactivator, as did the preparation of Tymin'ski and Czestochowska (11) , or plasmin activity, as did the lytic agent reported by Kunzer and Haberhausen (9) , it may be somewhat similar to the activator observed by the Polish investigators in the "hemoglobin-free" red cell membranes. In the present study, however, activator was found in the stroma-free hemolysate and proteolysis with little or no activator was found in the washed, ultracentrifuged stroma. EK differs markedly from the fibrinolytic potentiating factor (FP) described by Back et al. (10) which is dialyzable and heat-stable and does not activate plasminogen itself but requires activator for its potentiating activity.
EK, like UK and other "tissue activators" (27) , activates both bovine and human plasminogen. In contrast, EK is localized within the red cells and hydrolyzes BAMe and ALMe more rapidly than does UK. Further- The specific activity of EK prepared by DEAE chromatography was only about 750 CTA U/mg protein. However, on acrylamide-gel electrophoresis, one of the three bands had a specific activity of 11,000 CTA U; another had 3800 CTA U, and the third (representing 45% of the total protein in the preparation) had none. Since the amount of extraneous protein seems relatively small, a higher degree of purification would be expected unless a considerable amount of EK becomes denatured during preparation. In any event, the potential purification and specific activity are not yet known.
Erythrocytes may possibly play a role in physiologic thrombolysis. Hemolysis has been observed by electron microscopy during hemostasis after transection of a small mesenteric arteriole in a guinea pig (29), and nearly 15 mg of hemoglobin/100 ml serum was found in human blood coagulated for 30 min in siliconed or glass test tubes (30) . However, the relatively small amounts of activator released during hemolysis, and the tendency for a newly forming thrombus to adsorb activators, suggest that any thrombolytic effect would probable be localized in the thrombus.
